SLIM-2

Comparison between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention

Stage
inclusie
Medicine
DOAC
Population
ASCVD
Phase
IV
First Patient In
1 December 2025
Last Patient In
31 December 2027
Last Patient Last Visit
31 January 2028

Inclusion period, 742 days remaining

National Lead

dr. S. Rasoul

Cardioloog

Office Contact

L.C.M. Smit

Projectmanager

The page has expired.